Effects of a Structured Exercise Program on Cancer-Related Fatigue in Women Receiving Radiation Therapy for Breast Cancer



Status:Active, not recruiting
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 74
Updated:1/20/2019
Start Date:June 2013
End Date:December 2020

Use our guide to learn which trials are right for you!

Radiation therapy (RT) is often used to treat breast cancer. RT combined with breast surgery
is associated with better outcomes in early stage breast cancer compared to surgery alone.
Fatigue is one of the most important side effects of RT because it can decrease patients'
quality of life.

Studies found that physical activity (PA) may help to improve quality of life in cancer
survivors. PA has been reported to lower fatigue, anxiety, and depression. Physical
inactivity over a long period of time may lead to rapid energy and physical function loss.

PA intervention studies in patients undergoing RT have included mostly White patients. There
is no evidence on African American patients undergoing RT. The purpose of this study is to
examine the efficacy of a structured, moderate-intensity, aerobic exercise program in
reducing cancer-related fatigue in African Americans undergoing RT for localized breast
cancer.

* Purpose of project (one or two sentences): The objective of this study is to examine the
efficacy of a structured, moderate-intensity aerobic exercise program in reducing
cancer-related fatigue in African Americans undergoing RT for localized breast cancer.

2. * Study design (for example, hypothesis, research questions, standard and experimental
procedures/drugs/devices or equipment, etc.):

This is a randomized clinical trial to determine the efficacy of a structured,
moderate-intensity aerobic exercise program in reducing cancer-related fatigue. The study
occurs at a single-center setting. There are 30 breast cancer patient/subjects in all, a
portion of whom (n=15) will undergo a structured, moderate-intensity aerobic exercise
delivered via a stationary cycling device (peddlers).

The study duration would be 12 months, and the administration of the study would be 8 weeks.
The exercise program will be carried out at Washington Hospital Center while they wait for
radiation therapy treatments.

3. * Rationale and justification for study (i.e. historical background, investigator's
personal experience, pertinent medical literature, etc.): Given the widespread use of RT for
treatment of early stage breast cancers, and the identification of fatigue as an important
side-effect of RT, it is important to test interventions that can reduce fatigue and improve
the health-related quality of life (HRQOL) among survivors. PA interventions have been shown
to improve quality of life and reduce fatigue in cancer patients undergoing RT. However, most
studies on PA in RT-related fatigue and HRQOL have been conducted among Whites and evidence
on the efficacy of PA interventions in African Americans is lacking. Additionally, the timing
of introduction of PA with respect to the RT timeline is also unclear. Finally, although
preliminary studies suggest that fatigue might be related to inflammation, it is not clear
whether the effect of PA on fatigue is associated with changes in inflammatory biomarkers.
The purpose of this study is to test the efficacy of a structured PA intervention in reducing
cancer-related fatigue among African American patients undergoing RT for breast cancer.

This study is also designed to provide pilot data on i) the acceptability of, and adherence
with PA interventions in African Americans with breast cancer, and ii) the correlation of
inflammation markers with fatigue and PA.

4. * Primary objective: The purpose of this study is to test the efficacy of a structured PA
intervention in reducing cancer-related fatigue among African American patients undergoing RT
for breast cancer.

5. * Secondary objectives: To determine the efficacy of a structured, moderate-intensity
aerobic exercise program in improving HRQOL of African American patients undergoing RT for
localized breast cancer.

To determine the acceptability of, and adherence with a structured, exercise intervention
among African-American patients undergoing RT for localized breast cancer.

8.* Treatment Plan: 4.1 Randomization All participants (N=30) scheduled for radiotherapy will
be randomized to one of the two following groups: i) a 8-week structured, moderate-intensity
aerobic training exercise regimen concurrent with their radiation therapy (N=15), or ii)
usual care control group (N=15). Participants will be randomized into the study by a
bio-statistician once eligibility has been determined. All participants in the study will
undergo radiation therapy as scheduled by their physicians. The exercise intervention will
not interfere with either the dose or the timeline of their radiation therapy.

4.2 PA intervention Those participants randomized to the exercise group will be required to
exercise 5 days/week for 8 weeks coinciding with the radiation treatment sessions. The
exercise intervention will consist of aerobic training. Participants will be required to meet
and maintain a goal of 75 min/week of aerobic exercise by using portable cycle ergometers;
that is; 15 min/day for 5 days/week. The cycle ergometer consists of two cycling pedals
mounted to a stationary block that allows patients to exercise while sitting. The tension on
the pedals can be adjusted to provide desired tension. Patients can also move the equipment
so they can use it conveniently while sitting anywhere and with any chair.

9.* Primary Study Endpoint: The primary endpoints of the study are fatigue, HRQOL, and
biomarkers of inflammation.

Inclusion Criteria:

- -over 18 years old or less than 75 years old.

- histologically confirmed carcinoma of the breast

- radiation therapy naive

- sedentary, as defined as <60 minutes of recreation or work requiring modest PA/week
based on the 7 day physical activity recall questionnaire

- ambulatory

- negative serum pregnancy test and not planning to be pregnant in the next 3 months

- ability to understand and the willingness to sign a written informed consent.

- have breast cancer stage 0-IIIA

- completed neo-adjuvant or adjuvant chemotherapy may be concurrently receiving
endocrine or HER2 directed therapy

Exclusion Criteria:

- age less than 18 years old or more than 75 years

- no histological confirmation of breast cancer

- prior breast, chest or pelvic radiotherapy

- concurrent chemotherapy

- distant metastases

- physical limitations (e.g., orthopedic, central nervous system) that contraindicate
participation in a low to moderate intensity home-based walking program

- a positive pregnancy test, currently pregnant or planning to become pregnant in the
next three months

- identified as the active or maintenance stage of exercise behavior

- psychiatric disorder which would render the subject unable to provide informed
consent.
We found this trial at
1
site
Washington, District of Columbia 20010
?
mi
from
Washington,
Click here to add this to my saved trials